CytomX Therapeutics, Inc. (CTMX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 587.61M |
| Enterprise Value | 579.18M |
| P/E Ratio | -5.39 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 28.87 |
| Price/Book Ratio | 1.76 |
| Enterprise/Revenue | 28.24 |
| Enterprise/EBITDA | -6.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -4.35 |
| Operating Margin | -4.76 |
AD
Management Effectiveness
| Return On Assets | -0.21 |
| Return On Equity | -0.38 |
Income Statement
| Revenue | 76.2M |
| Revenue/Share | 0.08 |
| Gross Profit | 76.2M |
| EBITDA | -15.75M |
| Net Income | -17.37M |
| Diluted EPS | -0.15 |
Balance Sheet
| Total Cash | 330.28M |
| Total Cash/Share | 1.51 |
| Total Debt | 5.7M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 9.36 |
| Book Value Per Share | 1.38 |
Price History
| 52-Week Change | -33.01 |
| 52-Week High | 8.21 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 3 |
| Moving Average 200 Days | 3.95 |
Statistics
| Average Volume | 3.25M |
| Shares Outstanding | 217.9M |
| % Held by Institutions | 97.56 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
